Focus Taiwan App

Blood pressure medication recalled after carcinogenic substance found

11/20/2018 11:14 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan's Food and Drug Administration (FDA) has ordered the recall of high blood pressure medication produced by Hsinchu County-based Genovate Biotechnology Co. after the drug was found to contain a carcinogenic substance.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.